Special Issue "Cancer Stem Cells and Tumor Microenvironment"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (15 November 2015)
Dr. Vita Golubovskaya
1. Research and Business Development, Promab Biotechnologies, 2600 Hilltop Drive, Richmond, CA 94806, USA
2. Department of Medicine, University of Oklahoma, Oklahoma City, OK 73126, USA
Website | E-Mail
Interests: Immunotherapy; CAR-T cells; tumor microenvironment; checkpoint protein; hypoxia; tumor survival signaling
Cancer stem cells or tumor initiating cells overexpress specific intra- and extra-cellular markers that result in their tumorigenic and high metastatic activity. In addition, the unique intracellular signaling and metabolism of cancer stem cells drive aggressive behavior of these cells. Cancer stem cells cross talk with microenvironment components: immune cells, blood vessels, fibroblasts, extracellular matrix proteins), which is important to understand for future development of anti-cancer therapeutics. The genomics, proteomics, and metabolomics technology should be applied to the characterization of these cells and microenvironment to develop personalized medicine approaches.
Dr. Vita Golubovskaya
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer stem cells;
- extracellular matrix;
- immune cells;
- blood vessels;